To assess the specificity of the ELISA kit, we measured the levels of Ig G, A, M, and E as well as light chains in the plasma of ten randomized subjects, including a patient with multiple myeloma accompanying high levels of IgG and κ light chains. The gene discussed is GAN; the disease is AL amyloidosis.